Cellular senescence, an irreversible growth arrest, is considered to play as safeguard against malignant progression, though such a mechanism is speculative in human carcinogenesis. In gallbladder carcinoma, cholecystolithiasis and pancreaticobiliary maljunction (PBM) are major risk factors. Here, by using 113 surgically resected gallbladders and cultures of human gallbladder epithelial cells (HGECs) and gallbladder carcinoma cell line (TGBC2TKB), we examined carcinogenesis with respect to cellular senescence. Among 15 cases of PBM in which carcinoma was found in 4 cases, nonneoplastic gallbladder mucosa showed diffuse papillary hyperplasia (PHP). PHP was not found in gallbladders with cholecystolithiasis. Interestingly, PHP exhibited senescent features such as expression of p16
Gallbladder carcinoma is an aggressive and dismal disease, affecting mainly older people and women. 1, 2 Among risk factors for the development of gallbladder carcinoma, cholecystolithiasis is the most important. [1] [2] [3] Porcelain gallbladder, gallbladder adenoma and adenomyomatosis, and pancreaticobiliary maljunction (PBM) are also known as risk factors, and the carcinogenesis and precancerous lesions may be different in the gallbladder depending on the risk factors. [1] [2] [3] PBM is defined as the union of the pancreatic and common bile ducts outside the wall of the duodenum, beyond the influence of the sphincter of Oddi. [3] [4] [5] [6] [7] Normally, the pancreaticobiliary duct and junction are governed by sphincter, but as a result of the anomaly, pancreatic juice can reflex into the common bile duct. PBM patients are known to be associated with bile duct dilatation and also biliary tract carcinoma, especially in the Far East. [3] [4] [5] [6] [7] Patients who develop gallbladder carcinoma in association with PBM are usually 10 years younger than those without PBM. Synchronous primary cancers of the gallbladder and common bile duct have also been associated with PBM. Although PBM is reportedly rare in the West, 8 the impact of this disease in the biliary tract carcinogenesis deserves much attention of Western researchers and clinicians.
In the patients with PBM, the gallbladder shows frequently papillary hyperplasia (PHP) of the mucosa and PHP has been considered an important precursor lesion for gallbladder carcinoma. [3] [4] [5] It has been postulated in PBM that the reflex of pancreatic juice into the common bile duct and the stagnation of pancreatic juice mixed with bile have been considered to play an important role in the pathophysiology of PBM, including biliary tract carcinoma. [3] [4] [5] [6] [7] [8] [9] [10] A high concentration of lysolecithin (LL) was reported in the gallbladder bile of PBM, [3] [4] [5] [6] [7] and LL is produced from lecithin by activated phospholipase A2 in the refluxing pancreatic juice in PBM. LL and other altered bile components may be responsible for the development of PHP and also carcinoma of the gallbladder in PBM. [3] [4] [5] [6] [7] Although gallstones seem to be closely associated with gallbladder carcinoma, there is no evidence of direct causal relationship between them. Lining epithelia of the biliary tract including the gallbladder are known to show intraepithelial atypical/proliferative lesions closely associated with the development of carcinoma. 1, 11, 12 In the large bile ducts of hepatolithiasis, these lesions are named as biliary intraepithelial neoplasia (BilIN) and they are subdivided into BilIN-1(low-grade dysplasia), BilIN-2 (high-grade dysplasia), and BilIN-3 (carcinoma in situ).
11,12 Recently, we reported that these lesions show serial molecular changes along their progression. That is, the expression of p16
INK4A , a major tumor suppressor, was frequent in BilIN-1, but was decreased in BilIN-2/3 and invasive carcinoma. Instead, EZH2, a polycomb group transcriptional repressor, showed a stepwise increase from BilIN-1, -2, and -3 to invasive carcinoma, suggesting that overexpression of EZH2 followed by decreased expression of p16
INK4a is involved in the multistep carcinogenesis through BilINs of the large bile ducts of hepatolithiasis. 12 Amplification of EZH2 is reported in various cancers, 12, 13 and upregulation of EZH2 is reported to indicate an increased risk of neoplastic transformation. 14 In cholelcystolithiasis, however, the role of EZH2 and p16
INK4a in the precursor lesions and carcinoma remains speculative. Cellular senescence was first described as permanent growth arrest due to telomere attrition, and oxidative stress and DNA damage can also trigger senescence prematurely. [13] [14] [15] Senescence, particularly the telomere-independent form, is reported to act as a safeguard mechanism against malignant transformation. 16 For example, nevi composed of melanocytes showing cellular senescence may reside without malignant transformation for years. 17 As for the emergence of overt malignant tumors from the senescent state, acquisition of an escape mutation or expansion from a clone bypassing senescence is speculated. In patients with PBM, the gallbladder mucosa is known to continuously shows PHP from infants through to adults, 18 whereas the gallbladder carcinoma in PBM patients just increases with age with a peak at 50 years, [4] [5] [6] implying that the gallbladder mucosa showing PHP does not undergo malignant for decades, raising a possibility that PHP represents a senescent-related lesion against malignant transformation.
EZH2 is suggested to be involved in the regulation of p16 INK4a , an important factor in the process of senescence, and importantly, these two molecules seem to be involved in the biliary tract carcinogenesis. 12 There have been no studies on PHP with respect to cellular senescence and activation of EZH2. Furthermore, it remains only speculative what mechanism(s) prevent malignant transformation in the gallbladder for decades in patients with PBM, and what mechanisms initiate the gallbladder carcinoma in adult PBM patients.
In this study using gallbladders and cultures of gallbladder epithelial cells and gallbladder carcinoma cell line, we tried to evaluate carcinogenetic pathways in the presence of cholecystolithiasis and PBM. We also tried to examine the significance of PHP in the carcinogenesis in PBM with respect to EZH2 and cellular senescence.
MATERIALS AND METHODS Cellular Senescent Markers
In this study, p16
INK4A , SA-b-Gal, and gH2AX were used as a cellular senescence marker: p16 INK4A is often highly expressed in senescent cells in vitro. A relationship between senescenceassociated b-galactosidase (SA-b-Gal) activity and senescent cells is generally accepted, especially in cultured cells. 19 Recent studies suggest that DNA damage and DNA damage signaling are causative of different forms of senescence, including not only telomere dysfunction, but also oncogeneinduced senescence, 20 and H2AX, a variant of the nucleosome core histone H2A, undergoes phosphorylation at Ser 139 in response to DNA damage, and this phosphorylated H2AX has been named gH2AX.
21
Human Tissue Studies Classification of hyperplastic and neoplastic lesions of gallbladder We divided intraepithelial neoplasia of the lining epithelia of gallbladder into BilIN-1 (low-grade dysplasia), BilIN-2 (high-grade dysplasia), and BilIN-3 (carcinoma in situ).
11,12
The former two were collectively termed BilIN-1/2 ( Figure 1a and b), and BilIN-3 was included in gallbladder carcinoma (CarGB). CarGB was divided histologically into well, moderately, and poorly differentiated adenocarcinoma, and papillary carcinoma. PHP is characterized by diffuse papillary infolding of the lining tall epithelium of the gallbladder. There is no evident cytological or nuclear atypia.
Preparation of tissue specimens
The gallbladders from 15 patients with PBM, in which 4 cases were associated with carcinoma (BilIN-3 and invasive carcinoma), were used. Gallstones were not found in these cases. A total of 87 gallbladders with cholecystolithiasis were used: 10 with no BilIN lesions (CholGB), 39 with several foci of BilIN-1/2 lesions, and 38 with BilIN-3 and invasive carcinoma (CarGB; Table 1 ). In these cases, chronic cholecystitis was found in the nonneoplastic mucosa. CarGB cases including BIlIN-3 comprised of 11 well, 12 moderately, and 9 poorly differentiated adenocarcinomas, and 6 papillary adenocarcinomas. As normal controls, surgically resected gallbladders from 11 patients who underwent gastrectomy for Gallbladder cancer and cellular senescence J Yamaguchi et al gastric cancer and cholecystectomy, a part of a regular operation, were used (NorGB).
All these surgically resected gallbladders were fixed in 10% formalin. After embedding in paraffin, about 20 serial thin sections were cut from each block, and used for histological and immunohistochemical analyses. This study was approved by the Committee of Ethics in Kanazawa University.
Immunohistochemistry
The expressions of p16 INK4A , EZH2, gH2AX, and Ki-67 were assessed immunohistochemically in nonneoplastic and neoplastic gallbladders, using monoclonal antibodies: antip16 INK4A (clone JC2; Neomarkers, CA, USA), anti-EZH2 (clone 11; Transduction, San Jose, CA, USA), anti-gH2AX (clone JBW301; Upstate Biotech, Lake Placid, NY, USA), and anti-Ki67 (clone MIB-1; DAKO, Glostrup, Denmark), respectively. That is, deparaffinized sections were pretreated in EDTA buffer, pH 9 at 1211C for EZH2, or in citrate buffer, pH 6 at 1211C for p16 INK4A or in a microwave in citrate buffer (pH 6) at 951C, for Ki-67 and gH2AX. After the pretreatment with 1% H 2 O 2 in methanol to block endogenous peroxidase activity and then with Protein Block Serum to block nonspecific reactions, the sections were incubated overnight at 41C with each primary monoclonal antibody at the optimized dilutions. Thereafter, the sections were incubated with the secondary antibodies conjugated to a peroxidase-labeled polymer, the EnVision þ system (DAKO), or Histofine Simple Stain MAX PO (G) (Nichirei, Tokyo, Japan). A diaminobenzidine tetrahydrochloride solution containing hydrogen peroxide was used as the chromogen. For a negative control, a similar dilution of the control mouse IgG (DAKO) was applied.
Percentage of cells positive for p16 INK4A , EZH2, gH2AX, and Ki-67, was semiquantitatively calculated in high-power fields of two or three foci containing about 100 contiguous epithelial cells, and the mean was regarded as the labeling index (LI) of individual proteins in each case. LIs of p16 INK4A , EZH2, and gH2AX were compared among normal, hyperplastic, preneoplastic, and neoplastic lesions. Proliferative activities of these cells were assessed using Ki-67 LI.
Cell Culture Study Primary culture of human gallbladder epithelial cells Human gallbladder epithelial cells (HGECs) were established from a surgically resected gallbladder with cholecystolithiasis as described, 22 and grown as monolayers. Epithelial nature of these cells was confirmed by the expression of CK7. HGECs were incubated in a culture medium as described, and HGECs between passages 4 and 8 were used.
Culture of carcinoma cell line
The human gallbladder carcinoma cell line, TGBC2TKB (RCB1130), was provided by the Riken Cell Bank (Tsukuba, Japan). TGBC2TKB cells were maintained in DMEM containing 5% fetal bovine serum and antibiotic-antimyotic (Gibco, Rockville, MD, USA).
Preparation of model bile solutions
Model bile solution containing lysolecithin (MB-LL) and containing lecithin (control MB) were prepared for cell culture study. Cholesterol, Egg lecithin, egg lysolecithin, and sodium taurocholate were obtained from Sigma (St Louis, MO, USA) and stored at À801C. The procedures for model bile preparation were slight modifications of those described previously. 23 In brief, stock model bile solutions were prepared as follows. Aliquots of taurocholate in methanol, either of lecithin or lysolecithin in chloroform/methanol, and cholesterol in methanol were added to a vial equipped with a Teflon cap to yield the desired amount of these three lipids. All model bile solutions used in this study contained 9.6 mol % cholesterol, 8 g of total lipids per 100 ml, and a bile salt/ lecithin molar ratio of 2.3:1. After the mixture was flushed with nitrogen, it was shaken at 371C overnight, and the organic solvent was then evaporated under a stream of nitrogen until the mixture had condensed to a viscous paste. To complete solvent removal, the mixture was lyophilized. Lastly, the required volume of Hanks' balanced salt solution was added to preheated lyophilized lipids. The pH of each solution was adjusted to 7.5 and the mixture was flushed with nitrogen. The resultant suspension was shaken at a constant speed of 100 r.p.m. in environmental incubator shaker at 551C until microscopically isotropic (at least 24 h).
Assay for Cellular Senescence and Cell Proliferative Activity Cellular senescence SA-b-Gal activity was detected using a senescence detection kit (BioVision, Mountain View, CA, USA). The proportion of Cell proliferative activities Cell proliferative activity was assessed using 5-bromo-2 0 -deoxyuridine (BrdU) Labeling and Detection Kit I (Roche, Nonnenwald, Germany). The nuclei were simultaneously stained with 4 0 ,6-diamidino-2-phenylindole. At least 1 Â 10 3 cells were checked and counted to determine the BrdU-LI using a fluorescence microscope. Serial proliferation of the cells was assessed using Cell Proliferation Reagent WST-1 (Roche).
Western Blotting
Proteins were extracted from cultured cells using T-PER tissue protein extraction reagent (Pierce Chemical Co., Rockford, IL, USA), and the total amount of protein was measured spectrometrically. The 25 mg of the protein was subjected to 10% SDS-polyacrylamide electrophoresis and electrophoretically transferred onto a nitrocellulose membrane. The membrane was incubated with primary antibodies against anti-p16 INK4A (1:100; clone JC8; Santa Cruz), EZH2 (1:500), gH2AX (1:1000), and b-actin (1:5000; Abcam, Cambridge, UK). The protein expression was detected using a chemiluminescence kit (Thermo Scientific, Waltham, MA, USA).
RT-PCR
Total RNA (1 mg) was extracted from cultured cells using an RNA extraction kit (RNeasy Mini; Qiagen, Tokyo, Japan) and used to synthesize cDNA with reverse transcriptase (ReverTra Ace; Toyobo Co., Osaka, Japan). PCR amplification was performed in a total volume of 25 ml containing 1 ml of cDNA, 0.2 mmol/l dNTPs, 1 mmol/l each of 5 0 -and 3 0 -primers, and 2.5 U of TaqDNA polymerase (Takara EX Taq; Takara Bio) with an annealing temperature of 581C for p16, 541C for EZH2, and 561C for G3PDH. The sequences of the primers were as follows: EZH2, 5 0 -GTGGAGAGATTATTT CTCAAGATG-3 0 (forward) and 5 0 -CCGACATACTTCAGGG CATCAGCC-3 0 (reverse); p16, 5 0 -CCCGCTTTCGTAGTTTT CAT-3 0 (forward) and 5 0 -TTATTTGAGCTTTGGTTCTG-3 0 (reverse); and G3PDH, 5 0 -GAACGGGAAGCTCACTGGCAT GGC-3 0 (forward) and 5 0 -TGAGGTCCACCACCCTGTTGC Tg-3 0 (reverse). The number of PCR cycles was 27. For each reaction, an initial denaturation cycle of 941C and a final cycle of 721C were incorporated. The PCR products were subjected to 2% agarose gel electrophoresis and stained with ethidium bromide. A semiquantitative analysis of the gel image was performed using public domain NIH image software and the difference compared with G3PDH expression was calculated.
Knockdown of EZH2 by Small Interfering RNA Validated small interfering RNA (siRNA) for EZH2 and negative control siRNA were purchased from Santa Cruz Biotech (Santa Cruz, CA, USA) and Qiagen (Hilden, Germany), respectively. One day before transfection, cells were plated in 12-well plates (3-5 Â 10 4 cells) or Lab-Tek chambers (1 Â 10 4 cells), and then transiently transfected with either EZH2 or control siRNA (150 nM), using Lipofectamine 2000 (Invitrogen, Carlsbad, CA), according to the manufacturer's protocol.
Transfection of EZH2-Overexpression Vector
The EZH2-overexpression plasmid and control vector were transfected into HGECs using Lipofectamine 2000 (Invitrogen) according to the manufacture's protocol. The EZH2 plasmid was a kind gift from Dr. T Jenuwein (Research Institute of Moleclar Pathology, Vienna). 24 Immunofluorescence Staining of the Cultured Cells Cultured cells (HGECs and TGBC2TKB) grown in a Lab-Tek chamber were fixed and stained using the primary antibodies for gH2AX or p16
INK4A described above. After incubation with the primary antibodies overnight, and then Alexa-Flour 488-or 568-labelled anti-mouse IgG, the sections were observed under a fluorescence microscope.
Statistical Analysis
Data are expressed as the mean ± s.d. For comparisons of multiple groups, we used Welch's t-test. Differences with values of Po0.05 were considered significant.
RESULTS

Human Tissue Studies
In all 15 cases of PBM, the nonneoplastic mucosa showed PHP (Figure 1c and d) , but not BilIN-1/2. In four cases of PBM associated with CarGB, carcinoma was found in the background of PHP (Figure 1e ). In contrast, PHP was not found in gallbladder mucosa with cholecystolithiasis.
Expression of p16
INK4A and EZH2 EZH2 was expressed in the nuclei of gallbladder epithelial cells including carcinoma cells, whereas p16
INK4A was found in the nuclei and/or cytoplasm of these cells (Figure 2 ). EZH2 was clearly and frequently expressed in CarGB (LI, 56.2 ± 21.0%), whereas it was faint and infrequent in NorGB and CholGB (3.1 ± 5.2% and 9.5 ± 10.4%; Figure 3a) . EZH2 was strongly and frequently expressed in BilIN-1/2 in cholecystolithiasis, whereas its expression was faint and infrequent in PHP in PBM (Figure 2b and c) , and its LI was higher in the former (55.3±27.1%) than in the latter (20.3±21.9%; Po0.05; Figure 3a) . p16 INK4A was expressed variably in CarGB (16.4±28.5%), whereas its expression was negligible in NorGB and CholGB (0.3 ± 0.9% and 0.6 ± 1.9%). p16
INK4A was evidently and frequently expressed in PHP in comparison with BilIN-1/2 (Figure 2b and c) , and its LI was higher in PHP (45.0±22.7%) than in BilIN-1/2 (9.8±15.5%; Po0.05; Figure 3a ). When LI of EZH2 and that of p16
INK4A in BilIN1/ Expression of gH2AX gH2AX, a marker of DNA damage, was expressed in the nuclei of the epithelial cells in the form of multiple foci in nonneoplastic and neoplastic gallbladder epithelium. In contrast to p16 INK4A , which had a scattered distribution, gH2AX was homogeneously expressed in PHP (Figure 2c ). The expression of gH2AX was more frequent in PHP in PBM cases than in BilIN1/2 in cholecystolithiasis, and its LI was higher in PHP (44.6±35.9%) than in BilIN1/2 (15.6±17.8%; Po0.05). Its expression in CarGB (LI, 15.2 ± 12.9%) was comparable to BilIN1/2. Its LI in NorGB (10.5 ± 6.3%) and CholGB (6.9 ± 13.4%) were low in comparison with that in PHP (Figure 3a ).
BilIN-3 and invasive carcinoma in gallbladders with PBM and those with cholecystolithiasis
The above-mentioned immunohistochemical features of BilIN-3 and invasive carcinoma were similar between these two groups.
Cell Culture Studies Treatment of cultured HGECs by lysolecithin Induction of Growth Arrest in Cultured HGECs. Under the hypothesis that senescence occurs in the gallbladder of PBM and that a high concentration of LL in bile relates to such changes, we treated cultured HGECs with 100 mM LL, MB-LL (containing 100 mM LL) and control MB. As shown in Figure 4a , the proliferation of HGECs was markedly inhibited by the treatment with LL and to a lesser degree, by the treatment with MB-LL, with a plateau in the growth curve reached by day 4. As shown in Figure 4b , the proliferation of HGECs was inhibited by the treatment with control model bile with LL (50 mM), with a plateau in the growth curve reached by day 4. The growth rate was slightly high by day 4 in HGECs with this treatment. Relative cell numbers were markedly decreased by the treatment with control model bile with higher concentration of LL (100 and 150 mM), indicating cell death by these treatments. In vitro BrdU assay performed 4 days after the treatment with LL (100 mM) and MB-LL (containing 100 mM LL) showed that cell proliferative activity was significantly low in comparison to the solvent control and control MB (Figure 4c ).
Expression of Senescence Markers. We examined the expression of several markers of senescence in the growth-arrested HGECs induced by LL. The number of SA-b-Galpositive cells was significantly increased by LL treatment (100 mM, 4 days) and to a lesser degree, by MB-LL treatment (Figure 5a and b) . Immunofluorescence showed that gH2AX foci were present in the nuclei of HGECs treated with LL (100 mM, 4days; Figure 5c ). Western blot assays showed an increase of gH2AX and p16
INK4A in parallel in the cells treated with LL (Figure 5d ).
Overexpression of EZH2 in Senescent Cells Causes Reduced Expression of p16
INK4A . To clarify whether senescent cells can escape growth arrest or not, cultured HGECs were first Gallbladder cancer and cellular senescence J Yamaguchi et al treated with LL (100 mM) for 7 days so as to enter a senescent state, and then, transfected with the EZH2 expression plasmid (Figure 6a ). RT-PCR showed that the expression of p16 INK4A was considerably inhibited in contrary to that of EZH2 in the cells treated with the EZH2 plasmid in comparison to those treated with the control vector (Figure 6b ).
Studies using cultured human gallbladder carcinoma cells
Knockdown of EZH2 Results in Decrease in Proliferation. As the expression level of EZH2 was low in PHP in PBM and high in CarGB, we hypothesized that EZH2 induces escape/ bypass of cellular senescence. Therefore, we examined whether the knockdown of EZH2 by siRNA affects the proliferation and senescence of TGBC2TKB cells.
EZH2 level was high in TGBC2TKB cells in comparison to that in HGECs (Figure 7a ). RT-PCR showed the effective knockdown of EZH2 by siRNA treatment in comparison to the control siRNA treatment 1 day after treatment (Figure  7b ). In vitro BrdU assay was performed 2 days after the siRNA treatment in TGBC2TKB cells. Proliferative activity was significantly reduced after treatment with EZH2 siRNA in comparison to that in cells treated with control siRNA (Figure 7c) , suggesting that the knockdown of EZH2 by siRNA treatment decreased the proliferative activity of these TGBC2TKB cells.
Knockdown of EZH2 Induces SA-b-Gal and p16
INK4A Expression in TGBC2TKB Cells. To examine whether senescence may be responsible for the decreased cell proliferation caused by EZH2 siRNA, we examined the expression of senescence markers in TGBC2TKB cells treated with EZH2 siRNA. SA-bGal assay performed 4 days after the siRNA treatment showed that the number of SA-b-Gal -positive cells was significantly increased in comparison to the control (Figure 7d and e) . 
DISCUSSION
The results of this study can be summarized as follows: (1) PHP of the gallbladder mucosa was found in all cases of PBM but not in cholecystolithiasis, whereas BilIN-1/2 was found in cholecystolithiasis but not PBM. (2) BilIN-1/2 showed frequent expression of EZH2 and increased cellular proliferative activities as seen in CarGB including BilIN-3, whereas PHP showed an increased expression of p16 INK4A (a senescence marker) and formation of gH2AX foci (a DNA damage marker), and low cell proliferative activities. (3) LL induced the expression of senescence markers, and also the formation of gH2AX foci, and induced growth arrest in cultured HGECs. Enforced overexpression of EZH2 in senescent HGECs caused decreased expression of p16 INK4A . (4) Knockdown of EZH2 in cultured TGBC2TKB cells resulted in a decrease in cell proliferation and induced the expression of senescent markers.
Aberrant expression of EZH2 is regarded as a potential marker of aggressive cancers and also indicates an increased risk of malignant transformation. 14 In fact, our recent study showed that EZH2 was overexpressed in BilIN-1/2, BilIN-3, and invasive carcinoma of stone-containing intrahepatic large bile ducts. 12 This study also showed that EZH2 was Gallbladder cancer and cellular senescence J Yamaguchi et al Gallbladder cancer and cellular senescence J Yamaguchi et al frequently expressed in BilIN-1/2 and CarGB including BilIN-3 in cholecystolithiasis. Taken together, similar carcinogenetic processes may be operative in the large bile duct in hepatolithiasis and also in the gallbladder in cholecystolithiasis. Biliary tract carcinoma is frequently accompanied by PBM, [4] [5] [6] and in fact, CarGB was found in 4 of the 15 cases of PBM examined here. PHP was found in the gallbladder in all PBM cases and p16
INK4A was frequently expressed in PHP. p16
INK4A , a major tumor suppressor, is inactivated in a variety of human cancers. 12 Interestingly, it was found in this study that the expression level of EZH2 was inversely correlated with that of p16
INK4A in PHP and BilIN-1/2 in cholecystolithiasis; the p16 INK4A -predominant expression was exclusively found in PHP, and in contrast, EZH2 was predominant in BiIN-1/2. These differences between BilIN-1/2 and PHP suggest that the gallbladder carcinogenesis in PBM is different from that in cholecystolithiasis. However, EZH2 was similarly expressed in BilIN-3 and invasive carcinoma in the gallbladders with PBM as seen in those with cholecystolithiasis, suggesting that EZH2 also participates in the malignant transformation in PHP in the gallbladder of PBM patients, whereas BilIN-1/2 are not related to this carcinogenesis.
This study showed that the expression of p16 INK4A was highly frequent in PHP of the gallbladder of PBM. In addition, cell proliferative activities of PHP were quite low. Reportedly, p16
INK4A protein is frequently expressed in senescent cells in vivo, 25 and this protein is thought to be a causative factor of senescence. 25 p16 INK4A is also known as an effecter of in vitro oncogene-induced senescence. 26 Taken together, it seems possible that PHP lesion reflects cellular senescence.
Early tumorigenesis is associated with the DNA-damage checkpoint response (DDR), 27 which can arrest the cell cycle on detection of DNA damage. Activation of DDR contributes to oncogene-induced senescence, and senescent cells have clearly detectable foci of senescence-associated DNA-damage. These foci contain activated DDR mediators such as 53BP1 and MDC1, together with gH2AX. 21 This study showed that gH2AX was quite frequently expressed in PHP in the gallbladder in PBM, supporting that PHP lesions of the gallbladder of PBM patients represent a senescent state.
In human naevi, which is regarded as an oncogene-induced cellular senescent lesion, p16
